Gulf Capital and the Funding Chain Behind British Health Innovation
Reported talks over a 20 per cent stake in Panmure Liberum touch the mid-market broking channel on which UK life sciences and health-tech companies depend, and the link to NHS policy is indirect but consequential.
By
Distilled Post Editorial Team